Outcomes and practice patterns of medical management of blunt thoracic aortic injury from the Aortic Trauma Foundation global registry
Cassra N Arbabi,Joseph DuBose,Kristofer Charlton-Ouw,Benjamin W Starnes,Naveed Saqib,Elina Quiroga,Charles Miller,Ali Azizzadeh,Aortic Trauma Foundation Study Group,Rana Afifi,Michelle McNutt,Zain Al-Rustum,Binod Shrestha,Edmundo Dipasupil,Ben Starnes,Rami Gilani,David Turay,Xian Luo-Owen,Tiffany Bee,Suzanne Moyer,Joe DuBose,William Shutze,William Dockery,Laura Petrey,Timothy N Phelps,Chuck Fox,Ernest Moore,Alexis Cralley,Pedro Teixeira,Emily Leede,Frank Buchanan,Emilio Ramos,Marielle Ngoue,Nicole Fox,Lisa Shea,Martin Zielinski,Marianna Martini Fischmann,Kenji Inaba,Desmond Khor,Gregory Magee,Malachi Sheahan,Marie Unruh,Neil Parry,Luc Dubois,John Berne,Ivan Puente,Mario F Gomez,Dalier R Mederos,John Bini,Karen Herzing,Claire Hardman,Andres Schanzer,Francesco Aiello,Edward Arous,Elias Arous,Douglas Jones,Dejah Judelson,Louis Messina,Tammy Nguyen,Jessica Simons,Robert Steppacher,Joao Rezende-Neto,James Haan,Kelly Lightwine,Julie Dunn,Brittany Smoot,Tal Horer,David McGreevy,Vincent Riambau,Gaspar Mestres,Xavier Yugueros,Marc Passman,Adam W Beck,Mark Patterson,Ben Pearce,Emily Spangler,Graeme McFarland,Danielle Sutzko,Matt Smeds,Emad Zakhary,Michael Williams,Catherine Wittgen,Todd Vogel,Matt Eagleton,Bruce Gewertz,Galinos Barmparas,Cassra Arbabi,Rishi Kundi,Jonathan Morrison,Peter Rossi,Davide Pacini,Luca Botta,Ciro Amodio,Pierantonio Rimoldi,Ilenia D'Alessio,Nicola Monzio Compagnoni,Muhammad Aftab,Mohammed Al-Musawi,T Brett Reece,Jay D Pal,Donald Jacobs,Rafael D Malgor,Devin Zarkowsky,Ravi Rajani,Jaime Benarroch-Gampel,Christopher R Ramos,Marc Schermerhorn,Mark Wyers,Allen Hamdan,Lars Stangenberg,Andy Lee,Mark Davies,Lalithapriya Priya Jayakumar,Matthew J Sideman,Christopher Mitromaras,Dimitrios Miserlis,Reshma Brahmbhatt,Ralph Darling,Xzabia Caliste,Benjamin B Chang,Jeffrey C Hnath,Paul B Kreienberg,Alexander Kryszuk,Adriana Laser,Sean P Roddy,Stephanie Saltzberg,Melissa Shah,Courtney Warner,Chin-Chin Yeh,Viktor Reva,Viktor Zhigalo,Alexander V Krasikov,Santi Trimarchi,Maurizio Domanin,Trissa Babrowski,Ross Milner,Luka Pocivavsek,Christopher Skelly,Kimberly Malka,Brian Nolan,Mario D’Oria,Sandro Lepidi
DOI: https://doi.org/10.1016/j.jvs.2021.08.084
Abstract:Objective: Blunt thoracic aortic injury (BTAI) is the second leading cause of death from blunt trauma. In the present study, we aimed to determine the outcomes of medical management (MM) for BTAI. We hypothesized from the results of several previously reported studies, that patients with a minimal aortic injury (BTAI grades 1 and 2) could safely be treated with definitive MM alone. Methods: The Aortic Trauma Foundation international prospective multicenter registry was used to examine the demographics, injury characteristics, management, and outcomes of patients with BTAI. We analyzed a subset of patients for whom MM was initiated as definitive therapy. Results: From November 2016 to April 2020, 432 patients (median age, 41 years; 76% male; median injury severity score, 34) with BTAI (Society for Vascular Surgery grade 1, 23.6%; grade 2, 14.4%; grade 3, 51.2%; grade 4, 10.9%) were evaluated. Of the 432 patients, 245 (57%) had received MM in the initial period and 114 (26.4%) had received MM as the planned definitive therapy (grade 1, 59.6%; grade 2, 23.7%; grade 3, 15.8%; grade 4, 0.9%). The most common mechanism of BTAI was a motor vehicle collision (60.4%). Hypotension was present on arrival in 74 patients (17.2%). Continuous titratable infusion of antihypertensive medication was used for 49.1%, followed by intermittent bolus administration (29.8%), with beta-blockers (74.6%) the most common agent used. Treatments were targeted to a goal systolic blood pressure for 83.3%, most often to a target goal systolic blood pressure <120 mm Hg (66.3%). The MM goals based on blood pressure control were attained in 64.0% (73 of 114). Twelve patients (10.5%; grade 1, 1; grade 2, 0; grade 3, 10; grade 4, 1) had required subsequent intervention after MM. Eleven patients (9.6%) had undergone thoracic endovascular aortic repair and one (0.9%) had required open repair for a grade 4 injury. The overall in-hospital mortality for patients selected for definitive MM was 7.9%. No aortic-related deaths had occurred in the patients receiving definitive MM. Conclusions: Approximately one in four patients with BTAI will receive MM as definitive therapy. The variation in the pharmacologic therapies used is considerable. MM for patients with minimal aortic injury (BTAI grades 1 and 2) is safe and effective, with a low overall intervention rate and no aortic-related deaths. These findings support the use of definitive MM for grade 2 BTAI.